Revitalization
WORLDWIDE
Much like our bold vision for liver health, our headquarters are located in communities where revitalization is underway.
Much like our bold vision for liver health, our headquarters are located in communities where revitalization is underway.
10 Hudson Yards, 37th Floor | New York, NY 10001 | T: 646-747-1000
9520 Towne Centre Drive, Suite 200 | San Diego, CA 92121 | T: 858-652-6800
Two Pancras Square | Kings Cross, London,
N1C 4AG, UK | T:+44 203 805 7600
Fleischmarkt 1/6/12
A-1010 Vienna, Austria
T: +43 1 20 5107 3106
E: info-AT@interceptpharma.com
4263 Sherwoodtowne Blvd, Suite 300
Mississauga, ON
L4Z 1Y5
T: +1 877-559-ICPT (4278)
E: Info-Canada@Interceptpharma.com
Paris Madeleine
19, Boulevard Malesherbes
75008 Paris, France
T: +33 1 55 27 39 16
E: Interceptfrance@interceptpharma.com
Rosenheimer Str. 52
D-81669 München, Germany
T: +49 89 4111 124 11
E: info-DE@interceptpharma.com
Ormond Building
31-36 Ormond Quay Upper, Dublin 7, Dublin, Republic of Ireland
T: +353 15274019
E: info-Ireland@interceptpharma.com
Via Giosuè Carducci 24
20123 Milano, Italy
T: +39 02 66661030
E: info.italia@interceptpharma.com
Paris Madeleine
19, Boulevard Malesherbes
75008 Paris, France
T: +33 1 55 27 39 16
E: Interceptfrance@interceptpharma.com
Centro Empresarial Torres de Lisboa
Rua Tomás da Fonseca, Torre G, 1º Piso
1600-209 Lisboa
Portugal
T: +351 21 723 0729 or +351 21 723 0731
E: geral.pt@interceptpharma.com
City Center Stockerhof
Dreikönigstrasse 31A
8002 Zürich, Switzerland
T: +41 (0)44 208 3616
F: +41 (0)44 208 3500
E: info-CH@interceptpharma.com
Two Pancras Square
Kings Cross, London, N1C 4AG, UK
T: +44 203 805 7600
E: info-UK@interceptpharma.com
Since March 2018, Intercept has partnered with AOP Orphan Pharmaceuticals AG (HQ Vienna, Austria) in a number of European countries where Intercept does not have a direct affiliate presence. Although Intercept retains the Marketing Authorisation across Europe, AOP takes full commercialisation responsibility of OCALIVA in these countries.
Intercept is committed to ensuring transparency around interactions with Healthcare Professionals, Healthcare Organizations and Patient Organizations in line with legal and code obligations. The below links provide transparency disclosure information in these countries as they relate to Intercept:
You are now leaving Intercept Pharmaceuticals’ corporate website and entering a site intended for U.S. audiences only.
You are now leaving Intercept Pharmaceuticals’ corporate website. Intercept does not control or endorse the content of this external site.
The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website.
The site you will be entering is intended for U.S. audiences only.
If you are a healthcare provider looking for product information, visit ocalivahcp.com.
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.
Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed.
United States (US)
European Union (EU)
Canada
Israel
Switzerland
Australia
Liechtenstein
United Arab Emirates (UAE)
Exploring Racial Differences and Disparities in PBC Care